This is part of a blog series from genetic counselors at the Basser Center. This was written by Jessica M. Long, MS, LCGC.

This blog is part of a series featuring interviews with patient advocates. This was adapted from an interview with Dana Donofree, designer and founder of AnaOno Intimates, made for women with breast cancer by women with breast cancer. She is also a passionate patient advocate active in the breast cancer community.

This is part of an ongoing series featuring interviews with physicians on topics related to hereditary cancer. This is a summary of a discussion with Roger Greenberg, MD, PhD, the Basser Center’s Director of Basic Science and the Director of the new Penn Center for Genome Integrity.

This is part of a blog series from genetic counselors at the Basser Center. This was written by Jessica M. Long, MS, LCGC.

As part of an ongoing series of answers to common questions received by the Basser Center for BRCA, Executive Director Susan Domchek, MD, discusses PARP inhibitors and ways in which they might be combined with other cancer treatments.

A recent Wall Street Journal article described a family’s story with genetic testing, which included a very rare event: a reinterpretation of genetic test results from “likely harmful” to “uncertain.” The situation described in the article has raised concerns for some individuals with BRCA1 or BRCA2 mutations.

This is part of a blog series from genetic counselors at the Basser Center. This was written by Danielle McKenna, MS, LCGC.

This is part of an ongoing series featuring interviews with physicians on topics related to hereditary cancer. This article was written by Kara Maxwell, MD, PhD. Dr. Maxwell is a physician scientist with the Basser Center and the Abramson Cancer Center at the University of Pennsylvania. Her areas of expertise are in cancer genetics, specifically in hereditary cancer syndromes.

This is part of a blog series from genetic counselors at the Basser Center. This was written by Jessica Ebrahimzadeh, MS, LCGC.

Thanksgiving is a day set aside to express gratitude and share a meal with loved ones. Maybe your Thursday will be filled with traditions like watching football or scouting out Black Friday deals; but did you know that Thanksgiving Day is also National Family Health History Day?

This is part of an ongoing series featuring interviews with physicians on topics related to hereditary cancer. This article was adapted from an interview with Kim Reiss Binder, MD. Dr. Reiss Binder is a medical oncologist and clinical researcher with the Basser Center for BRCA and the Abramson Cancer Center at the University of Pennsylvania. Dr. Reiss Binder’s area of expertise is BRCA-related pancreatic cancer. She leads several clinical trials that aim to improve the treatment options and outcomes for this group of patients.